Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 16
1964 18
1965 11
1966 7
1967 22
1968 28
1969 37
1970 39
1971 46
1972 48
1973 48
1974 68
1975 53
1976 73
1977 51
1978 75
1979 82
1980 54
1981 57
1982 70
1983 111
1984 119
1985 135
1986 134
1987 167
1988 323
1989 317
1990 301
1991 338
1992 322
1993 345
1994 376
1995 434
1996 420
1997 460
1998 417
1999 372
2000 398
2001 391
2002 372
2003 440
2004 392
2005 392
2006 416
2007 439
2008 470
2009 478
2010 507
2011 580
2012 550
2013 650
2014 771
2015 677
2016 665
2017 699
2018 656
2019 627
2020 766
2021 774
2022 766
2023 605
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18,102 results

Results by year

Filters applied: . Clear all
Page 1
The epigenomics of sarcoma.
Nacev BA, Jones KB, Intlekofer AM, Yu JSE, Allis CD, Tap WD, Ladanyi M, Nielsen TO. Nacev BA, et al. Nat Rev Cancer. 2020 Oct;20(10):608-623. doi: 10.1038/s41568-020-0288-4. Epub 2020 Aug 11. Nat Rev Cancer. 2020. PMID: 32782366 Free PMC article. Review.
Epigenetic mechanisms of tumorigenesis have been implicated in mesenchymal tumours ranging from chondroblastoma and giant cell tumour of bone to chondrosarcoma, malignant peripheral nerve sheath tumour, synovial sarcoma, epithelioid sarcoma and Ewing sarco
Epigenetic mechanisms of tumorigenesis have been implicated in mesenchymal tumours ranging from chondroblastoma and giant cell tumour of bon …
Update on Uterine Mesenchymal Neoplasms.
Kertowidjojo EC, Bennett JA. Kertowidjojo EC, et al. Surg Pathol Clin. 2022 Jun;15(2):315-340. doi: 10.1016/j.path.2022.02.008. Epub 2022 May 20. Surg Pathol Clin. 2022. PMID: 35715164 Review.
This review focuses on recent advances in epithelioid and myxoid uterine mesenchymal neoplasms, a category of tumors whereby diagnostic criteria have been rapidly evolving due to advances in molecular testing. ...Novel developments in epithelioid and myxoid leiomyos …
This review focuses on recent advances in epithelioid and myxoid uterine mesenchymal neoplasms, a category of tumors whereby diagnost …
Uterine mesenchymal tumours: recent advances.
Momeni-Boroujeni A, Chiang S. Momeni-Boroujeni A, et al. Histopathology. 2020 Jan;76(1):64-75. doi: 10.1111/his.14008. Histopathology. 2020. PMID: 31846533 Review.
Recent application of molecular techniques has identified numerous lesions with distinctive genetic abnormalities and clinicopathological characteristics. Newly discovered uterine sarcoma subtypes include high-grade endometrial stromal sarcomas with BCOR genetic abnormalit …
Recent application of molecular techniques has identified numerous lesions with distinctive genetic abnormalities and clinicopathological ch …
Ewing sarcoma and Ewing-like tumors.
Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP. Sbaraglia M, et al. Virchows Arch. 2020 Jan;476(1):109-119. doi: 10.1007/s00428-019-02720-8. Epub 2019 Dec 4. Virchows Arch. 2020. PMID: 31802230 Review.
Interestingly, despite significant morphologic overlap, most of these entities tend to exhibit morphologic features predictive of the underlying molecular alteration. Ewing sarcoma is the prototype of round cell sarcoma whereas in CIC sarcomas, focal pleomorphism an …
Interestingly, despite significant morphologic overlap, most of these entities tend to exhibit morphologic features predictive of the underl …
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, De Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A, Ferraresi V, Ferrari A, Fletcher CDM, Garcia Del Muro X, Gelderblom H, Gladdy RA, Gouin F, Grignani G, Gutkovich J, Haas R, Hindi N, Hohenberger P, Huang P, Joensuu H, Jones RL, Jungels C, Kasper B, Kawai A, Le Cesne A, Le Grange F, Leithner A, Leonard H, Lopez Pousa A, Martin Broto J, Merimsky O, Merriam P, Miceli R, Mir O, Molinari M, Montemurro M, Oldani G, Palmerini E, Pantaleo MA, Patel S, Piperno-Neumann S, Raut CP, Ravi V, Razak ARA, Reichardt P, Rubin BP, Rutkowski P, Safwat AA, Sangalli C, Sapisochin G, Sbaraglia M, Scheipl S, Schöffski P, Strauss D, Strauss SJ, Sundby Hall K, Tap WD, Trama A, Tweddle A, van der Graaf WTA, Van De Sande MAJ, Van Houdt W, van Oortmerssen G, Wagner AJ, Wartenberg M, Wood J, Zaffaroni N, Zimmermann C, Casali PG, Dei Tos AP, Gronchi A. Stacchiotti S, et al. ESMO Open. 2021 Jun;6(3):100170. doi: 10.1016/j.esmoop.2021.100170. Epub 2021 Jun 2. ESMO Open. 2021. PMID: 34090171 Free PMC article. Review.
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvem
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ra
Small round cell sarcomas.
Cidre-Aranaz F, Watson S, Amatruda JF, Nakamura T, Delattre O, de Alava E, Dirksen U, Grünewald TGP. Cidre-Aranaz F, et al. Nat Rev Dis Primers. 2022 Oct 6;8(1):66. doi: 10.1038/s41572-022-00393-3. Nat Rev Dis Primers. 2022. PMID: 36202860 Review.
SRCSs comprise new entities defined by specific genetic abnormalities, namely EWSR1-non-ETS fusions, CIC-rearrangements or BCOR genetic alterations, as well as EWSR1-ETS fusions in the prototypic SRCS Ewing sarcoma. These gene fusions mainly encode aberrant oncogenic trans …
SRCSs comprise new entities defined by specific genetic abnormalities, namely EWSR1-non-ETS fusions, CIC-rearrangements or BCOR genetic alte …
Basic Knowledge in Soft Tissue Sarcoma.
Bourcier K, Le Cesne A, Tselikas L, Adam J, Mir O, Honore C, de Baere T. Bourcier K, et al. Cardiovasc Intervent Radiol. 2019 Sep;42(9):1255-1261. doi: 10.1007/s00270-019-02259-w. Epub 2019 Jun 24. Cardiovasc Intervent Radiol. 2019. PMID: 31236647 Review.
Sarcoma is rare and heterogenous with various subtypes having a different prognostic. ...Recently radiotherapy enhancer injected percutaneously in soft tissue sarcoma has proven benefit in increasing the rate of R0 complete surgical resection. ...
Sarcoma is rare and heterogenous with various subtypes having a different prognostic. ...Recently radiotherapy enhancer injected perc
Soft-tissue sarcoma.
Gilbert NF, Cannon CP, Lin PP, Lewis VO. Gilbert NF, et al. J Am Acad Orthop Surg. 2009 Jan;17(1):40-7. doi: 10.5435/00124635-200901000-00006. J Am Acad Orthop Surg. 2009. PMID: 19136426 Review.
Soft-tissue sarcomas of the extremities and pelvis are the most relevant to the orthopaedic surgeon. The patient with extremity soft-tissue sarcoma typically presents with a painless, enlarging mass. Advanced imaging techniques and biopsy, which are best done at tertiary r …
Soft-tissue sarcomas of the extremities and pelvis are the most relevant to the orthopaedic surgeon. The patient with extremity soft-tissue …
Soft-tissue sarcoma in adolescents and young adults.
Kunisada T, Nakata E, Fujiwara T, Hosono A, Takihira S, Kondo H, Ozaki T. Kunisada T, et al. Int J Clin Oncol. 2023 Jan;28(1):1-11. doi: 10.1007/s10147-022-02119-7. Epub 2022 Jan 27. Int J Clin Oncol. 2023. PMID: 35084598 Review.
Soft-tissue sarcoma is a rare cancer that accounts for approximately 1% of all malignant tumors. ...This study aimed to evaluate the clinical and pathological characteristics of soft-tissue sarcoma in adolescents and young adults. According to the Bone and Soft-Tiss …
Soft-tissue sarcoma is a rare cancer that accounts for approximately 1% of all malignant tumors. ...This study aimed to evaluate the …
Options for treating different soft tissue sarcoma subtypes.
Ray-Coquard I, Serre D, Reichardt P, Martín-Broto J, Bauer S. Ray-Coquard I, et al. Future Oncol. 2018 May;14(10s):25-49. doi: 10.2217/fon-2018-0076. Future Oncol. 2018. PMID: 29768052 Review.
Management of soft tissue sarcoma is increasingly subtype-dependent. Surgery is recommended for uterine leiomyosarcoma, with trabectedin being the preferred option for advanced disease when the treatment goal is long-term tumor stabilization. ...
Management of soft tissue sarcoma is increasingly subtype-dependent. Surgery is recommended for uterine leiomyosarcoma, with trabecte …
18,102 results
You have reached the last available page of results. Please see the User Guide for more information.